|
|
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑 & b2 \$ y0 X: n- c ]9 a- t0 Q
8 M7 S% b4 @9 n
今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了" K2 u2 r" a2 z% q5 ~, O4 a: R
2 x% }7 |$ H# M" G
头颈肿瘤BU入选ASCO 2025的研究
3 b* I5 ~8 ?5 a& [" A1 `Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.9 \1 \ @( [2 R1 W
肿瘤内科-头颈肿瘤科姜愚团队& h* R& B+ c* C" ~9 \4 B5 g
" Q* H& b9 _3 v2 k7 H% r3 O$ ~Neoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.& {9 H0 x& d/ F7 F7 g& K9 y" d( ?
肿瘤内科-头颈肿瘤科刘磊团队
" H' R5 e# e2 M& h1 Z& z# F: k, Z3 g u
9 o* q5 |' |2 w3 L: pA phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy.
. v# e& x1 l& v" K肿瘤内科-头颈肿瘤科刘磊团队
1 t8 F" z, _$ s) Y
; S, |2 J" G. K% O. QA phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy." n; o7 S4 a6 [0 O5 C! p
肿瘤内科-头颈肿瘤科刘磊团队
& i& _- |; A! N* u j
% b; O$ z$ L: E0 W8 W( k' t9 _! Rribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
( l/ E% H# f0 \肿瘤内科-头颈肿瘤科姜愚团队; I- a5 u4 ~) D/ u% J8 ^
|
|
[复制链接]
楼主